By Business/Source
Currency:AUD
2025/FY
Stock NameRevenueRatio
HyperImmune Products7.29M100.00%
By Country/Region
Currency:AUD
2025/FY
Stock NameRevenueRatio
Australia5.25M72.05%
United States1.66M22.76%
Canada378.71K5.20%